BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Applied DNA Sciences, Inc. (APDN) Reveals 72% Increase in Staff, New Building, 16 DNA-Marking Contracts and Future Roadmap


7/11/2013 10:06:46 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

STONY BROOK, NY--(Marketwired - July 11, 2013) - Applied DNA Sciences, Inc. (OTCBB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, anti-theft and product authentication solutions, today announced that its ongoing staff expansion has so far resulted in a 72% increase in scientific, quality, operational and other employees since January of the current year. The company now counts forty-eight staff in Stony Brook, NY, United Kingdom, and elsewhere. The expansion accommodates the company's worldwide growth, including a broader product array, and a growing sales pipeline. A more robust and larger plant is in place to support the expansion.

Company officials pointed to increasing number of contracts with suppliers of military electronics, a total of sixteen as of today, and calls for anti-theft assets, including those acquired from United Kingdom-based RedWeb Technologies, as examples of the increased demand.

"The addition of top-notch people and an improved facility are two keys to handling growth," said Dr. James A. Hayward, CEO and President of Applied DNA Sciences. "Our grow-the-company initiative will keep us steadily on the edge of science and innovation, something our customers have come to expect from us. We are prepared to deliver."

Dr. Hayward described the company's Technology Roadmap, which envisions a faster and higher-volume SigNature DNA marking platform, highly optimized rapid read, new breakthroughs in textile marking and authentication, and other forward steps in technology.

The company is currently moving into a new, 30,000 square foot building, with significantly larger and differentiated laboratory space, improved security arrangements, new staging, shipping and fulfillment centers, and an expanded front office.

"We will remain light on our feet and able to serve customers quickly and with precision," Dr. Hayward commented. "Our new infrastructure is built to empower that philosophy."

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2012 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.


MEDIA CONTACT:
Mitchell Miller
646-543-3373
fax: 631-444-8848

INVESTOR CONTACT:
Debbie Bailey
631-444-8090
fax: 631-444-8848

FCMN Contact:
Email Contact
Web site: http://www.adnas.com
Twitter: @APDN, @APDNInvestor.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->